Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dry eye disease
Pharma
Alcon gains first FDA prescription drug nod since Novartis split
Six years after being spun out from Novartis, Alcon has gained its first FDA approval for a prescription pharmaceutical.
Kevin Dunleavy
May 29, 2025 10:20am
Bausch + Lomb taps broadcaster Erin Andrews for dry eye campaign
Oct 8, 2024 10:50am
Bausch + Lomb debuts online resource to boost dry eye awareness
Jul 8, 2024 11:33am
J&J unloads eye drops line to acquisitive Bausch + Lomb
Jul 6, 2023 10:29am
Bausch + Lomb launches new social-media-led campaign
Jul 5, 2023 9:10am
Bausch + Lomb scoops up Novartis' dry eye med Xiidra for $2.5B
Jun 30, 2023 10:05am
